First Public Safety Studies Released on 7-OH, Kratom Compound

The first safety studies on 7-hydroxymitragynine (7-OH), a compound found in the kratom plant, are now available to the public. Kratom, an herbal substance gaining popularity for chronic pain management, contains 7-OH, which can produce both sedative and stimulant effects.

Dr. Jeff Smith of the Holistic Alternative Recovery Trust (HART) highlighted that, despite over 500 million reported doses in the last two years and only five adverse effects, more regulatory safeguards are needed. Mild side effects like headaches or gastrointestinal discomfort have been reported, but Smith argues these are minor compared to opioid risks.

Although the FDA has not approved 7-OH, it is sold in some stores. Colorado recently enacted the Daniel Bregger Act, limiting 7-OH levels in kratom products and requiring state registration for manufacturers. Advocates emphasize the need for clear labeling, age restrictions, and third-party testing to ensure consumer safety.

Read the full story at Denver7.